KU Leuven BREATHE (Laboratory of Respiratory Diseases and Thoracic Surgery)
A KU Leuven research laboratory in respiratory diseases and thoracic surgery whose clusters include lung transplantation, preservation and regeneration.
As of . Primary source: BREATHE, Respiratory Diseases and Thoracic Surgery (KU Leuven).
Summary
The KU Leuven department page for Respiratory Diseases and Thoracic Surgery (BREATHE) lists research clusters including one on lung transplantation, preservation and regeneration, as well as clusters on chronic airways diseases, interstitial lung disease and pulmonary vascular disease. The page of the lung transplantation cluster itself, opened on 2026-10-10, names Bart Vanaudenaerde, Dirk Van Raemdonck, Geert Verleden, Robin Vos and Laurens Ceulemans, and states that the group studies, in its large clinical lung transplant population, risk factors, cellular and molecular mechanisms of acute and chronic rejection, diagnostic tools and subsequent therapies, using imaging, histopathology and microarrays on lung tissue and patient BAL, blood and biopsies.
Details
- city
- Leuven
- country
- Belgium
- parent
- KU Leuven
Sources and links
Related
Linked from (derived)
- authors affiliated with: Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction
- authors affiliated with: Donor-derived cell-free DNA in chronic lung allograft dysfunction phenotypes: a pilot study
- affiliation named in PubMed record (BREATHE): Clinical predictors for restrictive allograft syndrome: A nested case-control study.
- affiliation named in PubMed record (BREATHE): A transcriptomic atlas of chronic lung allograft dysfunction.
- authors affiliated with: Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction
- authors affiliated with: European society for organ transplantation clinical practice guideline on prevention and treatment of chronic lung allograft dysfunction
- authors affiliated with: International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition
- authors affiliated with: Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres
- authors affiliated with: Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement
- performed at: Ventilatory capacity in CLAD is driven by dysfunctional airway structure
- coauthors at: A European multicentre, randomised controlled trial of pirfenidone in bronchiolitis obliterans syndrome after bilateral lung transplantation
- authors affiliated with: Early Economic Model of Extracorporeal Photopheresis and Other Treatments of Chronic Lung Allograft Dysfunction After Lung Transplantation
- authors affiliated with: Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
- authors affiliated with: Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
- authors affiliated with: Novel biomarkers of chronic lung allograft dysfunction: is there anything reliable?
- authors affiliated with: The ABC of transplant: ALAD, BLAD, and CLAD: definition and significance
- authors affiliated with: Global approaches to chronic lung allograft dysfunction: Toward evidence-based harmonization
- member of: Bart Vanaudenaerde
- member of: Geert Verleden
- member of: Robin Vos
Known gaps in this record
- funding sources
- founding year
- roles of the named investigators beyond the list on the cluster page
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.